This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Thomas C. Spoor, MD; John G. McHenry, MD

Arch Ophthalmol. 1993;111(5):632-635.

Abstract
• Objective.
—To determine the long-term success of optic nerve sheath decompression in preserving visual function in patients with pseudotumor cerebri (PTC).

Design.
—To define stability of visual fields, we reviewed 32 series of postoperative visual fields in patients who were undergoing optic nerve sheath decompression for PTC who had stable visual acuity and four or more fields during 6 to 60 months of follow-up. The SD of these series was 0.80 dB (±0.39 dB) of mean deviation. Fluctuations within 2 SDs of the 1-month postoperative field were ±–1.60 dB. We therefore defined stability as a mean deviation within 2 dB of the preoperative visual field; improvement, greater than 2-dB mean deviation, and worsening, less than 2-dB mean deviation. We then extended our review to include all patients (54 patients, 75 eyes) who underwent optic nerve sheath decompression for PTC, who were followed up with serial automated perimetry (Humphrey 30-2).

Results.
—Fifty-one eyes (68%) showed improvement (36%) or stabilization (32%) of visual function. Twenty-four eyes (32%) experienced deterioration of visual function after an initially successful optic nerve sheath decompression. The probability of failure from 3 to 5 years was.35 by life-table analysis.

Conclusion.
—Optic nerve sheath decompression effectively stabilizes or improves visual function in the majority of patients with PTC and visual loss. However, it may fail at any time after surgery. Patients with PTC need to be followed up routinely with automated perimetry to detect deterioration of visual function.

Author Affiliations
From the Department of Ophthalmology, Wayne State University School of Medicine, Detroit, Mich.

Footnotes
Accepted for publication January 4, 1993.

Reprint requests to Kresge Eye Institute of Wayne State University, 4717 St Antoine, Detroit, MI 48201 (Dr Spoor).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Idiopathic intracranial hypertension and visual function
Acheson
Br Med Bull 2007;0:ldl019v1-12.
ABSTRACT | FULL TEXT  

The Pathogenesis and Treatment of Optic Disc Swelling in Neurosarcoidosis: A Unique Therapeutic Response to Infliximab
Katz et al.
Arch Neurol 2003;60:426-430.
ABSTRACT | FULL TEXT  

Macroglial Alterations after Isolated Optic Nerve Sheath Fenestration in Rabbit
Villain et al.
IOVS 2002;43:120-128.
ABSTRACT | FULL TEXT  

Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure?
WALKER
J. Neurol. Neurosurg. Psychiatry 2001;71:1-5.
FULL TEXT  

Idiopathic intracranial hypertension: Relationship to depression, anxiety, and quality of life
Kleinschmidt et al.
Neurology 2000;54:319-319.
ABSTRACT | FULL TEXT  

Optic Nerve Sheath Decompression With Adjunctive Mitomycin and Molteno Device Implantation
Spoor et al.
Arch Ophthalmol 1994;112:25-26.
ABSTRACT